{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Frio-bravo-qweek.simplecast.com%2Fepisodes%2Fepisode-217-testicular-cancer-rwx1JNDg","width":444,"version":"1.0","type":"rich","title":"Episode 217: Testicular Cancer","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/e7f25359-702b-47e8-97f2-d7f32a376648/89b65036-b2fa-4527-9fd4-f80317fd5fc8/rio_bravo_qweek_podcastlogonew.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/555fc45f-13fc-4506-b6fa-c6031f5d8a3e\" height=\"200\" width=\"100%\" title=\"Episode 217: Testicular Cancer\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"Episode 217: Testicular Cancer\n\nBrandon Noorvash (MS-III) and Ebenezer Dadzie, MD (PGY-1) review the recognition, evaluation, and management of testicular cancer in primary care, including epidemiology, risk factors, clinical presentation, diagnostic workup, and treatment principles. Dr. Arreaza asks insightful questions to guide the discussion and highlight key teaching points for clinicians.\n\nWritten by Brandon Noorvash, MS-III, Western University of Health Sciences; and Ebenezer Dadzie, MD, PGY-1, Clinica Sierra Vista Family Medicine Residency Program. Comments by Hector Arreaza, MD.\n"}